MNA
IDXX icon

Manning & Napier Advisors’s Idexx Laboratories IDXX Stock Holding History

Manning & Napier Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-42,431
Closed -$21.4M – 292
2024
Q3 		$21.4M Buy
42,431
+522
+1% +$254K 0.24% 81
2024
Q2 		$20.4M Buy
+41,909
New +$21M 0.23% 81

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Manning & Napier Advisors's IDXX Position: Q4 2024 in Review

Manning & Napier Advisors sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 42,431 shares — an estimated $21.4M sold.

Manning & Napier Advisors first reported a position in IDXX in Q2 2024 and held it in 2 quarters. The position peaked at $21.4M in Q3 2024. 1,123 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Manning & Napier Advisors reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Manning & Napier Advisors sold 42,431 Idexx Laboratories shares in Q4 2024, an estimated $21.4M.
  • Manning & Napier Advisors first reported a position in Idexx Laboratories in Q2 2024 and held it in 2 quarters.
  • Manning & Napier Advisors's Idexx Laboratories position peaked at $21.4M in Q3 2024.
  • 1,123 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Manning & Napier Advisors's 13F filing for Q4 2024, filed 23 Jan 2025.